Alnylam Pharmaceuticals, Inc.

Report date
3/31/2025
Quarter
2025 Q1
Filed
5/12/2025
Shares
6,704
Value ($000)
1,810
Weight
0.1%
2020 Q1 - 2025 Q1 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).